Aerius(Clarinex) MSD: Compound Profile
Aerius(Clarinex) MSD is a desloratadine-containing antihistamine formulation developed by Merck Sharp & Dohme (MSD) for research applications investigating H1-receptor antagonism and allergic response pathways. As a second-generation antihistamine compound, desloratadine serves as a valuable research tool for examining selective histamine receptor modulation in laboratory models. This pharmaceutical-grade preparation provides researchers with a standardised reference material for conducting controlled studies on allergic mechanisms, inflammatory cascade interactions, and receptor pharmacology investigations within controlled laboratory environments.
Research teams studying antihistamine pharmacokinetics will find this MSD formulation particularly valuable for examining bioavailability, metabolic pathways, and tissue distribution patterns. The compound’s well-characterised molecular profile makes it suitable for comparative studies against other H1-receptor antagonists, enabling researchers to evaluate relative binding affinities and selectivity profiles across different experimental models.
Laboratory Research Applications
Scientists investigating allergic response mechanisms utilise Aerius(Clarinex) MSD to examine histamine-mediated inflammatory pathways in cellular and tissue-based research models. The compound’s selective H1-receptor antagonism properties make it valuable for studying mast cell degranulation, basophil activation, and downstream inflammatory mediator release in controlled experimental settings. Researchers at Stroid UK Shop employ this compound to investigate antihistamine efficacy profiles and duration of action characteristics.
Pharmacological research teams study this formulation to examine drug-drug interaction potential, metabolic enzyme involvement, and receptor binding kinetics. The compound serves as a reference standard for comparative antihistamine studies, allowing researchers to evaluate novel H1-antagonist compounds against established therapeutic benchmarks. Studies examining desloratadine mechanisms benefit from this pharmaceutical-grade preparation’s consistent formulation characteristics.
Analytical chemistry laboratories utilise Aerius(Clarinex) MSD for developing and validating detection methods, studying degradation pathways, and examining formulation stability under various environmental conditions. Research teams investigating antihistamine biomarkers and metabolite identification employ this compound as a reference material for mass spectrometry and chromatographic method development. The compound also supports research into selective receptor modulation and protein-drug interactions within broader pharmacological investigation frameworks.
Specifications
| Product Name | Aerius(Clarinex) MSD |
|---|---|
| SKU | EU2158 |
| Manufacturer | MSD (Merck Sharp & Dohme) |
| Active Compound | Desloratadine |
| CAS Number | Verify with supplier |
| Molecular Formula | Verify with supplier |
| Storage Requirements | Store as per manufacturer guidelines |
| Research Grade | Pharmaceutical standard |
Compliance Statement
This product is supplied strictly for in-vitro laboratory research purposes only. Aerius(Clarinex) MSD is not intended for human consumption, therapeutic application, or any use outside controlled research environments. Researchers must ensure compliance with all applicable laboratory safety protocols, institutional guidelines, and regulatory requirements governing the handling and study of antihistamine compounds in research settings. All experimental work must be conducted by qualified personnel in appropriately equipped laboratory facilities with proper safety measures and waste disposal procedures in place.
